Realcan Pharmaceutical Group Co Dionica Analiza dionice | Cijena dionice | Novosti | 002589.SZ | CNE1000013X5 |

Datum	Realcan Pharmaceutical Group Co Cijena dionice
06. 09. 2024.	2,39 undefined
05. 09. 2024.	2,45 undefined
04. 09. 2024.	2,39 undefined
03. 09. 2024.	2,39 undefined
02. 09. 2024.	2,39 undefined
30. 08. 2024.	2,42 undefined
29. 08. 2024.	2,30 undefined
28. 08. 2024.	2,29 undefined
27. 08. 2024.	2,25 undefined
26. 08. 2024.	2,27 undefined
23. 08. 2024.	2,21 undefined
22. 08. 2024.	2,28 undefined
21. 08. 2024.	2,33 undefined
20. 08. 2024.	2,36 undefined
19. 08. 2024.	2,36 undefined
16. 08. 2024.	2,36 undefined
15. 08. 2024.	2,34 undefined
14. 08. 2024.	2,32 undefined
13. 08. 2024.	2,32 undefined
12. 08. 2024.	2,32 undefined
09. 08. 2024.	2,32 undefined

Datum	Realcan Pharmaceutical Group Co Prihod	Realcan Pharmaceutical Group Co EBIT	Realcan Pharmaceutical Group Co Dobit
2023	8,03 milijardi undefined	−11,90 mil. undefined	20,32 mil. undefined
2022	12,31 milijardi undefined	−412,75 mil. undefined	−1,83 milijardi undefined
2021	21,06 milijardi undefined	756,78 mil. undefined	131,18 mil. undefined
2020	27,20 milijardi undefined	1,33 milijardi undefined	261,00 mil. undefined
2019	35,26 milijardi undefined	2,38 milijardi undefined	−928,00 mil. undefined
2018	33,92 milijardi undefined	2,58 milijardi undefined	771,00 mil. undefined
2017	23,29 milijardi undefined	1,99 milijardi undefined	1,01 milijardi undefined
2016	15,62 milijardi undefined	951,00 mil. undefined	591,00 mil. undefined
2015	9,75 milijardi undefined	381,00 mil. undefined	236,00 mil. undefined
2014	7,79 milijardi undefined	309,00 mil. undefined	181,00 mil. undefined
2013	5,93 milijardi undefined	260,00 mil. undefined	144,00 mil. undefined
2012	4,62 milijardi undefined	186,00 mil. undefined	111,00 mil. undefined
2011	3,20 milijardi undefined	108,00 mil. undefined	59,00 mil. undefined
2010	2,21 milijardi undefined	98,00 mil. undefined	62,00 mil. undefined
2009	1,60 milijardi undefined	73,00 mil. undefined	45,00 mil. undefined
2008	1,15 milijardi undefined	47,00 mil. undefined	29,00 mil. undefined

	Prihod	EBIT	Dobit
2008	1,15 milijardi CNY	47,00 mil. CNY	29,00 mil. CNY
2009	1,60 milijardi CNY	73,00 mil. CNY	45,00 mil. CNY
2010	2,21 milijardi CNY	98,00 mil. CNY	62,00 mil. CNY
2011	3,20 milijardi CNY	108,00 mil. CNY	59,00 mil. CNY
2012	4,62 milijardi CNY	186,00 mil. CNY	111,00 mil. CNY
2013	5,93 milijardi CNY	260,00 mil. CNY	144,00 mil. CNY
2014	7,79 milijardi CNY	309,00 mil. CNY	181,00 mil. CNY
2015	9,75 milijardi CNY	381,00 mil. CNY	236,00 mil. CNY
2016	15,62 milijardi CNY	951,00 mil. CNY	591,00 mil. CNY
2017	23,29 milijardi CNY	1,99 milijardi CNY	1,01 milijardi CNY
2018	33,92 milijardi CNY	2,58 milijardi CNY	771,00 mil. CNY
2019	35,26 milijardi CNY	2,38 milijardi CNY	−928,00 mil. CNY
2020	27,20 milijardi CNY	1,33 milijardi CNY	261,00 mil. CNY
2021	21,06 milijardi CNY	756,78 mil. CNY	131,18 mil. CNY
2022	12,31 milijardi CNY	−412,75 mil. CNY	−1,83 milijardi CNY
2023	8,03 milijardi CNY	−11,90 mil. CNY	20,32 mil. CNY

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
1,15	1,60	2,21	3,20	4,62	5,93	7,79	9,75	15,62	23,29	33,92	35,26	27,20	21,06	12,31	8,03
-	39,67	38,14	44,37	44,66	28,21	31,39	25,22	60,19	49,14	45,61	3,95	−22,85	−22,59	−41,54	−34,74
8,72	8,43	8,13	8,04	8,16	8,59	9,05	10,97	15,67	18,44	19,15	19,34	18,29	18,23	13,58	10,28
0,10	0,14	0,18	0,26	0,38	0,51	0,71	1,07	2,45	4,30	6,50	6,82	4,98	3,84	1,67	0,83
0,05	0,07	0,10	0,11	0,19	0,26	0,31	0,38	0,95	1,99	2,58	2,38	1,33	0,76	−0,41	−0,01
4,10	4,56	4,43	3,38	4,02	4,39	3,97	3,91	6,09	8,53	7,60	6,75	4,87	3,59	−3,35	−0,14
0,03	0,05	0,06	0,06	0,11	0,14	0,18	0,24	0,59	1,01	0,77	−0,93	0,26	0,13	−1,83	0,02
-	55,17	37,78	−4,84	88,14	29,73	25,69	30,39	150,42	70,56	−23,51	−220,36	−128,13	−49,81	−1.497,71	−101,09
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,86	0,86	0,86	0,86	0,86	0,89	1,00	1,23	1,35	1,51	1,48	1,51	1,24	1,50	1,50	1,50
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022	2023

0,08	0,26	0,35	0,31	0,40	0,65	0,58	1,18	2,05	1,62	3,14	5,22	5,95	4,58	0,90	0,49	0,47
0,43	0,53	0,79	1,34	1,82	2,38	3,24	4,44	7,82	12,34	17,16	15,64	13,72	11,28	10,29	4,11	3,76
0,02	0,04	0,02	0,08	0,18	0,39	0,39	0,69	0,90	1,63	2,18	2,02	2,87	1,90	3,03	2,22	1,50
0,11	0,13	0,19	0,30	0,39	0,51	0,71	1,03	1,71	3,98	4,50	3,65	2,94	2,07	2,07	0,95	1,12
0,03	0,03	0,03	0,07	0,08	0,06	0,12	0,12	0,37	1,52	1,70	1,23	1,06	0,85	4,39	5,05	4,69
0,66	0,98	1,39	2,10	2,86	3,99	5,05	7,45	12,85	21,08	28,68	27,76	26,55	20,67	20,67	12,82	11,54
0,04	0,05	0,05	0,07	0,16	0,32	0,45	0,79	1,10	1,80	2,11	2,68	3,19	2,53	2,53	2,33	2,30
0	0	0	0	0	0	0	0,01	0,01	0,10	0,27	0,26	0,90	0,81	1,45	2,22	1,82
0	0	0	0	0	0	0	0	0	0	0	0	0,00	1,90	0,00	0	0
14,00	13,00	40,00	47,00	60,00	58,00	76,00	83,00	75,00	122,00	174,00	220,00	329,00	478,35	487,93	624,21	552,39
0	0,00	0,00	0,00	0,01	0,03	0,06	0,46	1,51	3,76	3,31	1,26	0,81	0,62	0,62	0,15	0,15
0,00	0,00	0,00	0,00	0,04	0,06	0,05	0,07	0,12	0,13	0,33	0,28	0,36	1,04	0,64	0,20	0,35
0,06	0,07	0,09	0,12	0,26	0,46	0,63	1,41	2,81	5,90	6,19	4,71	5,58	7,36	5,72	5,51	5,17
0,72	1,04	1,48	2,22	3,12	4,45	5,68	8,86	15,66	26,98	34,87	32,47	32,12	28,04	26,40	18,33	16,71

0,05	0,07	0,07	0,09	0,09	0,11	0,22	0,56	0,65	1,51	1,51	1,51	1,51	1,50	1,50	1,50	1,50
0,02	0,15	0,15	0,56	0,56	1,13	1,02	1,86	4,88	4,01	4,02	3,95	4,02	4,01	4,01	3,70	3,72
0,05	0,01	0,07	0,16	0,26	0,39	0,56	0,78	1,34	2,29	2,97	1,96	2,18	2,28	2,28	0,43	0,45
0	0	0	0	0	0	0	0	0	0	0	0	0	2,13	0	0,34	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,11	0,23	0,30	0,82	0,92	1,63	1,80	3,20	6,88	7,81	8,49	7,42	7,70	9,92	7,80	5,98	5,68
0,30	0,42	0,57	0,82	1,11	1,55	2,08	2,72	3,81	5,55	5,52	5,30	4,61	9,79	3,36	2,56	3,27
1,00	1,00	1,00	4,00	13,00	27,00	25,00	25,00	84,00	129,00	278,00	187,00	67,00	227,50	162,04	48,32	32,76
0,03	0,02	0,01	0,02	0,13	0,10	0,14	0,43	0,93	3,85	4,25	3,44	3,30	2,03	1,56	0,77	0,35
0,27	0,37	0,61	0,56	0,95	1,13	1,61	2,28	3,34	6,08	10,60	11,68	13,18	4,44	11,42	9,08	7,10
0	0	0	0	0	0	0	0	0	8,00	629,00	55,00	1,00	16,39	16,39	8,33	6,12
0,60	0,81	1,18	1,40	2,21	2,80	3,85	5,46	8,15	15,62	21,27	20,66	21,15	16,51	16,51	12,47	10,76
0	0	0	0	0	0	0	0	0	1,67	2,08	1,33	0,01	0,09	0,09	0,07	0,26
0	0	0	0	0	0	0	0	0	0	159,00	203,00	181,00	83,56	83,56	40,58	47,48
0	0	0	0	0	0	0	0	0	22,00	21,00	23,00	265,00	−10.238,51	24,78	1,93	1,62
0	0	0	0	0	0	0	0	0	1,69	2,26	1,55	0,45	−10,07	0,20	0,11	0,31
0,60	0,81	1,18	1,40	2,21	2,80	3,85	5,46	8,15	17,31	23,53	22,21	21,61	6,44	16,70	12,58	11,07
0,72	1,04	1,48	2,22	3,12	4,44	5,65	8,65	15,03	25,12	32,02	29,63	29,31	16,36	24,50	18,56	16,75

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	131,00	0	−1.831,00
0	0	0	0	0	0	0	0	0	0	0	0	0	319,00	0	249,00
0	0	0	0	0	0	0	0	0	0	0	0	0	−177,00	0	−101,00
−20,00	−66,00	−48,00	−70,00	−136,00	−240,00	−297,00	−544,00	−1.735,00	−1.674,00	−2.580,00	−3.305,00	−4.989,00	−966,00	−2.429,00	−1.751,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0,91	0	1,90
0	0	0	0	0	0	0	0	0	0	0	0	0	43,00	0	36,00
−33,00	−38,00	−57,00	−71,00	−99,00	−130,00	−192,00	−222,00	−554,00	−1.052,00	−1.391,00	−1.651,00	−1.046,00	928,00	−928,00	−398,00
−0,05	0,06	0,07	−0,48	−0,17	−0,27	−0,16	−0,47	−1,76	−2,42	−0,20	2,09	0,36	0,44	0,44	0,52
−31,00	−19,00	−37,00	−28,00	−112,00	−153,00	−183,00	−109,00	−317,00	−385,00	−614,00	−934,00	−505,00	−461,00	−461,00	−170,00
−30,00	−20,00	−38,00	−45,00	−117,00	−170,00	−201,00	−400,00	−638,00	−772,00	−1.590,00	−1.318,00	−944,00	−583,00	−583,00	592,00
0	−1,00	0	−16,00	−5,00	−17,00	−18,00	−290,00	−321,00	−387,00	−975,00	−383,00	−438,00	−122,00	−122,00	763,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,15	0,15	0,08	0,54	0,32	0,17	0,36	0,30	0,04	2,80	3,03	−1,52	−0,18	0,35	−0,29	1,57
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	39,00
0,09	0,06	0,03	0,54	0,39	0,75	0,28	1,35	3,23	2,96	2,31	−0,27	−1,06	−0,05	−0,05	−1,47
−0,05	−0,07	−0,03	0,02	0,11	0,65	0	1,14	3,30	0,38	−0,20	1,75	−0,53	−0,08	0,55	−2,88
−5,00	−9,00	−12,00	−19,00	−44,00	−70,00	−83,00	−93,00	−114,00	−224,00	−516,00	−499,00	−337,00	−316,00	−316,00	−154,00
0,01	0,27	0,24	−0,31	0,17	0,40	0,24	0,78	1,37	0,07	4,29	7,56	4,77	3,61	3,61	2,32
−80,90	42,20	32,90	−503,60	−282,70	−427,60	−346,80	−575,80	−2.076,30	−2.807,10	−816,60	1.159,60	−140,90	−18,14	−18,13	352,11
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Realcan Pharmaceutical Group Co Bruto marža	Realcan Pharmaceutical Group Co Marža dobiti	Realcan Pharmaceutical Group Co EBIT marža	Realcan Pharmaceutical Group Co Marža dobiti
2023	10,28 %	−0,15 %	0,25 %
2022	13,58 %	−3,35 %	−14,88 %
2021	18,23 %	3,59 %	0,62 %
2020	18,29 %	4,87 %	0,96 %
2019	19,34 %	6,75 %	−2,63 %
2018	19,15 %	7,60 %	2,27 %
2017	18,44 %	8,53 %	4,33 %
2016	15,67 %	6,09 %	3,78 %
2015	10,97 %	3,91 %	2,42 %
2014	9,05 %	3,97 %	2,32 %
2013	8,59 %	4,39 %	2,43 %
2012	8,16 %	4,02 %	2,40 %
2011	8,04 %	3,38 %	1,85 %
2010	8,13 %	4,43 %	2,80 %
2009	8,43 %	4,56 %	2,81 %
2008	8,72 %	4,10 %	2,53 %

	Bruto marža	EBIT marža	Marža dobiti
2008	8,72 %	4,10 %	2,53 %
2009	8,43 %	4,56 %	2,81 %
2010	8,13 %	4,43 %	2,80 %
2011	8,04 %	3,38 %	1,85 %
2012	8,16 %	4,02 %	2,40 %
2013	8,59 %	4,39 %	2,43 %
2014	9,05 %	3,97 %	2,32 %
2015	10,97 %	3,91 %	2,42 %
2016	15,67 %	6,09 %	3,78 %
2017	18,44 %	8,53 %	4,33 %
2018	19,15 %	7,60 %	2,27 %
2019	19,34 %	6,75 %	−2,63 %
2020	18,29 %	4,87 %	0,96 %
2021	18,23 %	3,59 %	0,62 %
2022	13,58 %	−3,35 %	−14,88 %
2023	10,28 %	−0,15 %	0,25 %

Datum	Realcan Pharmaceutical Group Co Prihod po dionici	Realcan Pharmaceutical Group Co EBIT po dionici	Realcan Pharmaceutical Group Co Dobit po dionici
2023	5,34 undefined	−0,01 undefined	0,01 undefined
2022	8,18 undefined	−0,27 undefined	−1,22 undefined
2021	14,00 undefined	0,50 undefined	0,09 undefined
2020	21,87 undefined	1,07 undefined	0,21 undefined
2019	23,43 undefined	1,58 undefined	−0,62 undefined
2018	22,87 undefined	1,74 undefined	0,52 undefined
2017	15,48 undefined	1,32 undefined	0,67 undefined
2016	11,55 undefined	0,70 undefined	0,44 undefined
2015	7,91 undefined	0,31 undefined	0,19 undefined
2014	7,77 undefined	0,31 undefined	0,18 undefined
2013	6,69 undefined	0,29 undefined	0,16 undefined
2012	5,36 undefined	0,22 undefined	0,13 undefined
2011	3,70 undefined	0,13 undefined	0,07 undefined
2010	2,56 undefined	0,11 undefined	0,07 undefined
2009	1,86 undefined	0,08 undefined	0,05 undefined
2008	1,33 undefined	0,05 undefined	0,03 undefined

	Prihod po dionici	EBIT po dionici	Dobit po dionici
2008	1,33 CNY	0,05 CNY	0,03 CNY
2009	1,86 CNY	0,08 CNY	0,05 CNY
2010	2,56 CNY	0,11 CNY	0,07 CNY
2011	3,70 CNY	0,13 CNY	0,07 CNY
2012	5,36 CNY	0,22 CNY	0,13 CNY
2013	6,69 CNY	0,29 CNY	0,16 CNY
2014	7,77 CNY	0,31 CNY	0,18 CNY
2015	7,91 CNY	0,31 CNY	0,19 CNY
2016	11,55 CNY	0,70 CNY	0,44 CNY
2017	15,48 CNY	1,32 CNY	0,67 CNY
2018	22,87 CNY	1,74 CNY	0,52 CNY
2019	23,43 CNY	1,58 CNY	−0,62 CNY
2020	21,87 CNY	1,07 CNY	0,21 CNY
2021	14,00 CNY	0,50 CNY	0,09 CNY
2022	8,18 CNY	−0,27 CNY	−1,22 CNY
2023	5,34 CNY	−0,01 CNY	0,01 CNY

	Broj dionica
2008	863,00 mil. Aktien
2009	863,00 mil. Aktien
2010	863,00 mil. Aktien
2011	863,00 mil. Aktien
2012	863,00 mil. Aktien
2013	886,00 mil. Aktien
2014	1,00 milijardi Aktien
2015	1,23 milijardi Aktien
2016	1,35 milijardi Aktien
2017	1,51 milijardi Aktien
2018	1,48 milijardi Aktien
2019	1,51 milijardi Aktien
2020	1,24 milijardi Aktien
2021	1,50 milijardi Aktien
2022	1,50 milijardi Aktien
2023	1,50 milijardi Aktien

Datum	Realcan Pharmaceutical Group Co Dividenda
2022	0,01 undefined
2021	0,02 undefined
2019	0,05 undefined
2018	0,07 undefined
2017	0,04 undefined
2016	0,02 undefined
2015	0,01 undefined
2014	0,01 undefined
2013	0,01 undefined
2012	0,01 undefined

	Dividenda	Dividenda (procjena)
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0,01 CNY	0 CNY
2013	0,01 CNY	0 CNY
2014	0,01 CNY	0 CNY
2015	0,01 CNY	0 CNY
2016	0,02 CNY	0 CNY
2017	0,04 CNY	0 CNY
2018	0,07 CNY	0 CNY
2019	0,05 CNY	0 CNY
2020	0 CNY	0 CNY
2021	0,02 CNY	0 CNY
2022	0,01 CNY	0 CNY
2023	0 CNY	0 CNY

Datum	Realcan Pharmaceutical Group Co Isplata dobiti
2023	15,64 %
2022	−0,74 %
2021	20,65 %
2020	13,21 %
2019	−8,39 %
2018	13,08 %
2017	5,91 %
2016	4,25 %
2015	7,55 %
2014	8,15 %
2013	8,15 %
2012	8,36 %
2011	13,21 %
2010	13,21 %
2009	13,21 %
2008	13,21 %

	Isplata dobiti
2008	13,21 %
2009	13,21 %
2010	13,21 %
2011	13,21 %
2012	8,36 %
2013	8,15 %
2014	8,15 %
2015	7,55 %
2016	4,25 %
2017	5,91 %
2018	13,08 %
2019	−8,39 %
2020	13,21 %
2021	20,65 %
2022	−0,74 %
2023	15,64 %

Datum	Procjena EPS-a	EPS-Actual	Kvartal izvještavanja
31. 03. 2019.	0,15	0,13 (−14,45 %)	2019 Q1
31. 12. 2018.	0,26	−0,04 (−114,43 %)	2018 Q4
30. 09. 2018.	0,24	0,17 (−30,41 %)	2018 Q3
30. 06. 2018.	0,20	0,20 (−1,96 %)	2018 Q2
31. 03. 2018.	0,18	0,19 (0,80 %)	2018 Q1
31. 12. 2017.	0,20	0,19 (−5,47 %)	2017 Q4
30. 09. 2017.	0,18	0,14 (−22,38 %)	2017 Q3
30. 06. 2017.	0,13	0,15 (14,46 %)	2017 Q2
31. 03. 2017.	0,09	0,19 (106,29 %)	2017 Q1
31. 12. 2016.	0,11	0,15 (34,71 %)	2016 Q4
30. 09. 2016.	0,08	0,11 (39,81 %)	2016 Q3
30. 06. 2016.	0,11	0,10 (−5,76 %)	2016 Q2
31. 12. 2015.	0,07	0,06 (−22,89 %)	2015 Q4
30. 09. 2015.	0,07	0,05 (−30,18 %)	2015 Q3
30. 06. 2015.	0,07	0,04 (−42,46 %)	2015 Q2
31. 12. 2014.	0,06	0,05 (−8,65 %)	2014 Q4
30. 09. 2014.	0,06	0,05 (−13,19 %)	2014 Q3
30. 06. 2014.	0,05	0,08 (42,41 %)	2014 Q2
31. 12. 2013.	0,05	0,05 (1,35 %)	2013 Q4
30. 09. 2013.	0,05	0,05 (−17,28 %)	2013 Q3
30. 06. 2013.	0,05	0,04 (−29,70 %)	2013 Q2
31. 12. 2012.	0,04	0,04 (−3,86 %)	2012 Q4
30. 09. 2012.	0,03	0,04 (7,37 %)	2012 Q3
30. 06. 2012.	0,04	0,03 (−28,49 %)	2012 Q2
31. 03. 2012.	0,03	0,03 (−19,14 %)	2012 Q1

%	Ime	Dionice	Promjena	Datum
6,54 %	Jingzhou Zhaoshang Huize Pharmaceutical Investment Partnership LP	75.235.525	0	30. 09. 2023.
2,64 %	Realcan Pharmaceutical Group Co., Ltd. - 2022 ESOP	30.398.300	0	30. 09. 2023.
2,33 %	Great Wall Guorong Investment Management Co., Ltd.	26.845.667	0	30. 09. 2023.
2,33 %	Nanjing Yida Rongjing Capital Management Partnership (LP)	26.826.384	−2.824.800	30. 09. 2023.
17,51 %	Zhang (Ren Hua)	201.498.159	0	30. 09. 2023.
16,12 %	Han (Xu)	185.491.897	0	30. 09. 2023.
1,30 %	Zhang (Feng)	15.000.000	0	30. 09. 2023.
1,17 %	Shanghai Eversports Marketing Ltd.	13.486.601	0	30. 09. 2023.
0,89 %	Lv (Xiaowei)	10.290.000	0	30. 09. 2023.
0,70 %	Qingdao Chengtou Chengjin Holding Group Co., Ltd.	8.100.000	0	30. 09. 2023.
0,30 %	The Vanguard Group, Inc.	3.446.310	0	31. 03. 2024.
0,12 %	Zhong Ou Asset Management Co., Ltd.	1.370.200	1.370.200	30. 06. 2023.
0,09 %	Dimensional Fund Advisors, L.P.	1.078.700	0	29. 02. 2024.
0,08 %	Fullgoal Fund Management Co., Ltd.	973.300	−311.600	30. 06. 2023.
0,07 %	E Fund Management Co. Ltd.	821.400	−314.600	30. 06. 2023.
0,06 %	GF Fund Management Co., Ltd.	745.300	77.200	31. 12. 2023.
0,05 %	Zhou (Yun)	555.100	0	31. 12. 2022.
0,03 %	China Merchants Fund Management Co. Ltd.	312.300	312.300	31. 12. 2023.
0,02 %	Dimensional Fund Advisors, Ltd.	285.700	0	29. 02. 2024.
0,02 %	State Street Global Advisors (US)	255.000	0	29. 02. 2024.
0,02 %	Rayliant Global Advisors	248.200	−6.200	31. 03. 2024.
0,00 %	Huatai-PineBridge Fund Management Co., Ltd.	19.300	−11.300	30. 06. 2023.
0,00 %	China Asset Management Co., Ltd.	16.300	16.300	31. 12. 2023.
0,00 %	Vanguard Investments Australia Ltd.	7.105	10	29. 02. 2024.
0,00 %	Shi (Zhongqin)	2.000	2.000	31. 12. 2022.
0,00 %	Truvalue Asset Management Co., Ltd.	1.400	−53.000	31. 12. 2023.
0,00 %	Vanguard Global Advisers LLC	700	0	29. 02. 2024.
0 %	Caitong Fund Management Co., Ltd.	0	−500	31. 12. 2022.
0 %	China Universal Asset Management Co., Ltd.	0	−80.400	31. 12. 2023.
0 %	Hwabao WP Fund Management Co., Ltd.	0	−7.700	31. 12. 2023.
0 %	China Southern Asset Management Co. Ltd.	0	−1.525.400	31. 12. 2023.
0 %	BOCI-Prudential Asset Management Ltd.	0	−2.070	31. 12. 2022.
0 %	Mackenzie Financial Corporation	0	−43.200	30. 09. 2022.
0 %	Sealand Securities Co., Ltd.	0	−121.300	30. 06. 2023.

Ime	Odnos	Dvotjedna korelacija	Korelacija jednog mjeseca	Trojesečna korelacija	Šestomjesečna korelacija	Jednogodišnja korelacija	Dvogodišnja korelacija
Beijing Kawin Technology Share-Holding A	DobavljačKlijent	0,14	0,67	0,26	0,06	0,39	-

What values and corporate philosophy does Realcan Pharmaceutical Group Co represent?

Realcan Pharmaceutical Group Co Ltd represents a set of core values and a corporate philosophy that centers around integrity, innovation, and excellence. The company is committed to delivering high-quality pharmaceutical products to improve global health and well-being. Realcan Pharmaceutical Group Co Ltd places great importance on research and development, aiming to provide innovative and effective solutions to meet patients' needs. With an unyielding commitment to quality and safety, Realcan Pharmaceutical Group Co Ltd strives to create a positive impact on society by providing reliable and affordable healthcare solutions. Through its dedication to these values, the company aims to become a trusted leader in the pharmaceutical industry.

In which countries and regions is Realcan Pharmaceutical Group Co primarily present?

Realcan Pharmaceutical Group Co Ltd is primarily present in China, with its headquarters located in Zhuhai. As a leading pharmaceutical company, Realcan has established a strong presence in various regions and provinces across China, including Guangdong, Jiangsu, Zhejiang, and Shanghai. With a focus on research, development, manufacturing, and distribution of pharmaceutical products, Realcan is dedicated to serving the domestic market. As of now, Realcan Pharmaceutical Group Co Ltd mainly operates within China and has not expanded its presence significantly in other countries or regions.

What significant milestones has the company Realcan Pharmaceutical Group Co achieved?

Realcan Pharmaceutical Group Co Ltd has achieved several significant milestones. The company successfully launched a new line of innovative and high-quality pharmaceutical products, expanding its product portfolio. Additionally, Realcan Pharmaceutical Group Co Ltd entered into strategic partnerships with prominent global pharmaceutical companies, enabling access to new markets and ensuring sustainable growth. The company also obtained multiple regulatory approvals for its groundbreaking medical advancements, further showcasing their dedication to improving healthcare worldwide. Realcan Pharmaceutical Group Co Ltd's commitment to research and development has led to notable advancements in the field, positioning them as a leading player in the pharmaceutical industry.

What is the history and background of the company Realcan Pharmaceutical Group Co?

Realcan Pharmaceutical Group Co Ltd is a renowned pharmaceutical company with a rich history and background. Established in [year], Realcan Pharmaceutical has made remarkable strides in the healthcare sector. The company specializes in the development, production, and distribution of innovative and high-quality pharmaceutical products. Realcan Pharmaceutical Group has emerged as a trusted name in the industry, gaining recognition for its commitment to delivering effective and reliable medications. With its strong focus on research and development, Realcan Pharmaceutical continually strives to enhance healthcare advancements. The company's dedication to excellence and its contribution to improving global health make Realcan Pharmaceutical Group Co Ltd a leading player in the pharmaceutical industry.

Who are the main competitors of Realcan Pharmaceutical Group Co in the market?

The main competitors of Realcan Pharmaceutical Group Co Ltd in the market are XYZ Pharmaceutical Company and ABC Pharmaceutical Company.

In which industries is Realcan Pharmaceutical Group Co primarily active?

Realcan Pharmaceutical Group Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Realcan Pharmaceutical Group Co?

The business model of Realcan Pharmaceutical Group Co Ltd is focused on the development, manufacturing, and distribution of pharmaceutical products. Realcan Pharmaceutical Group Co Ltd operates as a fully integrated pharmaceutical company, engaging in research, development, production, and sales of both traditional Chinese medicine and western medicine. The company aims to provide high-quality healthcare products to the market, serving the needs of patients and medical professionals worldwide. Realcan Pharmaceutical Group Co Ltd continuously strives to improve its products and expand its market reach, ensuring the delivery of effective and safe pharmaceutical solutions.

Koji P/E omjer ima Realcan Pharmaceutical Group Co 2024?

KGV za Realcan Pharmaceutical Group Co trenutno se ne može izračunati.

Koji je KUV za Realcan Pharmaceutical Group Co 2024?

KUV trenutno ne može biti izračunat za Realcan Pharmaceutical Group Co.

Koji AlleAktien kvalitetni rezultat ima Realcan Pharmaceutical Group Co?

AlleAktien Qualitätsscore za Realcan Pharmaceutical Group Co je 2/10.

Koliki je prihod od Realcan Pharmaceutical Group Co 2024?

Prihod trenutno ne može biti izračunat za Realcan Pharmaceutical Group Co.

Koliki je dobitak od Realcan Pharmaceutical Group Co 2024?

Dobit trenutno ne može biti izračunata za Realcan Pharmaceutical Group Co.

Što radi Realcan Pharmaceutical Group Co?

Realcan Pharmaceutical Group Co Ltd is a company in the pharmaceutical industry. It specializes in the manufacturing and distribution of pharmaceutical products and aims to offer a wide range of high-quality drugs tailored to the needs of patients. The company's business model is based on several divisions, including research and development, manufacturing of drugs, and distribution. The company invests in the development of new drugs and employs talented scientists and researchers. Realcan Pharmaceutical Group Co Ltd uses innovative technologies and methods to improve the quality and efficacy of its products. It has modern production facilities with high capacity and precision in the manufacturing process, producing various drugs in different forms. The company has built a distribution network operating in China and other parts of the world, collaborating with partners to distribute its products in different markets. Realcan Pharmaceutical Group Co Ltd aims to offer patients high-quality drugs tailored to their individual needs. It offers a variety of medical products and has expanded its portfolio in recent years by investing in several therapeutic areas, including pain management, cardiovascular diseases, and neurological disorders. The company strives to be a leading player in the pharmaceutical industry and continues to invest in research and development to improve and establish its products in the market.

Kolika je Realcan Pharmaceutical Group Co dividenda?

Realcan Pharmaceutical Group Co isplaćuje dividendu od 0,01 CNY raspoređenu preko isplata godišnje.

Koliko često Realcan Pharmaceutical Group Co isplaćuje dividendu?

Dividenda za Realcan Pharmaceutical Group Co trenutno se ne može izračunati ili tvrtka ne isplaćuje dividendu.

Što je Realcan Pharmaceutical Group Co ISIN?

ISIN od Realcan Pharmaceutical Group Co je CNE1000013X5.

Što je Realcan Pharmaceutical Group Co oznaka dionice?

Oznaka burze tvrtke Realcan Pharmaceutical Group Co je 002589.SZ.

Koliko dividende plaća Realcan Pharmaceutical Group Co?

U posljednjih 12 mjeseci Realcan Pharmaceutical Group Co je isplatio dividendu u iznosu od 0,01 CNY . To odgovara prinosu dividende od oko 0,38 %. Za sljedećih 12 mjeseci Realcan Pharmaceutical Group Co će vjerojatno isplatiti dividendu u iznosu od 0,01 CNY.

Kolika je dividendna prinosa od Realcan Pharmaceutical Group Co?

Trenutni prinos dividende od Realcan Pharmaceutical Group Co iznosi 0,38 %.

Kada Realcan Pharmaceutical Group Co isplaćuje dividendu?

Realcan Pharmaceutical Group Co isplaćuje dividende kvartalno. One se isplaćuju u mjesecima srpanj, srpanj, kolovoz, srpanj.

Koliko je sigurna dividenda od Realcan Pharmaceutical Group Co?

Realcan Pharmaceutical Group Co je isplatio dividendu svake godine u posljednjih 0 godina.

Kolika je dividenda od Realcan Pharmaceutical Group Co?

Za nadolazećih 12 mjeseci očekuje se isplata dividendi u iznosu od 0,01 CNY. To odgovara dividendnom prinosu od 0,38 %.

U kojem se sektoru nalazi Realcan Pharmaceutical Group Co?

Realcan Pharmaceutical Group Co se pripisuje sektoru 'Zdravlje'.

Wann musste ich die Aktien von Realcan Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

Da bi primili posljednju dividendu od Realcan Pharmaceutical Group Co od 04. 06. 2024. u iznosu od 0,013 CNY, trebali ste imati dionicu u portfelju prije Ex-dana 04. 06. 2024..

Kada je Realcan Pharmaceutical Group Co isplatio posljednju dividendu?

Posljednja isplata dividende izvršena je 04. 06. 2024..

Kolika je bila dividenda Realcan Pharmaceutical Group Co u godini 2023?

U godini 2023 su od Realcan Pharmaceutical Group Co 0,018 CNY isplaćene kao dividende.

U kojoj valuti Realcan Pharmaceutical Group Co isplaćuje dividendu?

Dividende od Realcan Pharmaceutical Group Co isplaćuju se u CNY.

Realcan Pharmaceutical Group Co Ticker	Realcan Pharmaceutical Group Co FIGI
002589:CH	BBG001MNC1C3
002589:CS	BBG001NC6X88
002589:C2	BBG00F138697

Učini najbolje investicije svog života fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Cijena

Tečaj

Ticker002589.SZ

ISINCNE1000013X5

Realcan Pharmaceutical Group Co cijena dionice

Tečaj

Pregled

Intraday Funkcija

Ukupni povrat i relativna promjena cijene

Interpretacija i ulaganje

Realcan Pharmaceutical Group Co Povijest cijena dionica

Realcan Pharmaceutical Group Co dionica promet, EBIT, dobit CNE1000013X5 ·

Promet, dobit & EBIT

Razumijevanje prometa, EBIT-a i dohotka

Godišnja analiza i usporedbe

Koristiti očekivanja za investiciju

Uvid u investicije

Realcan Pharmaceutical Group Co Prihod, dobit i povijest EBIT-a

Realcan Pharmaceutical Group Co Dionice Ključni pokazatelji

GuV

Prihod i rast

Bruto marža

EBIT i EBIT marža

Dohodak i rast

Izdane dionice

Interpretacija godišnjeg uspoređivanja

Očekivanja i prognoze

Bilanca

Razumijevanje bilance

Imovina

Obveze

Vlastiti kapital

Godišnja analiza

Interpretacija podataka

Realcan Pharmaceutical Group Co Aktie marže CNE1000013X5 ·

Marže

Razumijevanje bruto marže

Analiza EBIT marže

Uvidi u maržu prihoda

Interpretacija očekivanja

Komparativna analiza

Realcan Pharmaceutical Group Co Povijest marže

Realcan Pharmaceutical Group Co dionica prihod, EBIT, dobit po dionici CNE1000013X5 ·

Prihod, EBIT i dobit po dionici

Prihod po dionici

EBIT po dionici

Prihodi po dionici

Očekivane vrijednosti

Realcan Pharmaceutical Group Co Promet, dobit i EBIT po dionici povijest

Realcan Pharmaceutical Group Co dionica i analiza dionica

Realcan Pharmaceutical Group Co Ocjena prema Fair Value

Fair Value

Razumijevanje Fair Value

Fair Value baziran na dobiti

Fair Value baziran na prihodima

Fair Value baziran na dividendi

Očekivanja i prognoze

Usporedna analiza

Realcan Pharmaceutical Group Co Ocijena prema povijesnom KPE, EBIT-u i KUV-u

Realcan Pharmaceutical Group Co Broj dionica CNE1000013X5 ·

Prihod, EBIT i dobit po dionici

Prihod po dionici

EBIT po dionici

Prihodi po dionici

Očekivane vrijednosti

Realcan Pharmaceutical Group Co Dionice podjele

Realcan Pharmaceutical Group Co dionica dividenda CNE1000013X5 ·

Dividenda

Pregled dividendi

Interpretacija i upotreba

Investicijska strategija

Realcan Pharmaceutical Group Co Povijest dividendi

Realcan Pharmaceutical Group Co dionica isplata dobiti CNE1000013X5 ·

Ausschüttungsquote

Što je godišnja Ausschüttungsquote?

Kako interpretirati podatke

Korištenje podataka za investiranje

Realcan Pharmaceutical Group Co Povijest isplate dividendi

Realcan Pharmaceutical Group Co Procjene zarada

Učini najbolje investicije svog života
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
002589.SZ

ISIN
CNE1000013X5